Nebula Research & Development LLC Neurocrine Biosciences Inc Transaction History
Nebula Research & Development LLC
- $618 Billion
- Q2 2024
A detailed history of Nebula Research & Development LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Nebula Research & Development LLC holds 13,649 shares of NBIX stock, worth $1.7 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
13,649Holding current value
$1.7 Million% of portfolio
0.3%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
621Shares Held
95.2MCall Options Held
661KPut Options Held
221K-
Black Rock Inc. New York, NY14.2MShares$1.76 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.25 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$573 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$307 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$294 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...